💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Australia's Victoria state records another day of high coronavirus infections

Published 11/07/2020, 12:14 pm
Updated 11/07/2020, 12:18 pm
GILD
-

SYDNEY, July 11 (Reuters) - Australia's second most-populous state on Saturday reported one of its highest daily increases in new coronavirus infections and warned the numbers would get worse before they got better as it began its first weekend under a six-week lockdown.

Victoria state recorded 216 new cases of the virus that causes COVID-19 in the 24 hours to Saturday morning, down from a record 288 cases the previous day but still one of the biggest daily increases of any part of the country since the pandemic arrived.

The state put its capital city, Melbourne, into lockdown this week amid concern that community transmission was causing a second wave of the virus. The authorities had previously attributed most new cases to people returning from overseas.

"It will get worse before it gets better," Victorian Premier Daniel Andrews told a televised news conference.

"We will see more and more additional cases. This is going to be with us for months and months."

"Nobody is enjoying being locked at home. It is frustrating, it is challenging, but the strategy will be successful if we all play our part."

There were 100 separate outbreaks in Victoria, the state's chief health officer, Brett Sutton, told the news conference.

Australia has avoided the high COVID-19 casualty numbers of other countries after closing its borders and going into nationwide lockdown in March. The country has recorded about 9,200 infections and 107 deaths, including the death of a man in his 90s in Victoria overnight, Andrews said.

The country's other states have been relaxing restrictions on movement but tightened their border closures to Victoria. Victoria, home to a quarter of the country's 25 million people, has also become the first state to ask people to wear masks.

Though there is no proven vaccine or cure for the coronavirus, Australia gave provisional approval to Gilead Sciences Inc 's GILD.O remdesivir as the first treatment option for virus, joining the United States and the European Commission which have given it conditional clearance.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.